Cargando…
Changes in peripheral blood immune cell population in thyroid cancer patients treated with lenvatinib
This study evaluated changes in the peripheral blood immune cell population in patients with advanced thyroid cancer receiving lenvatinib treatment to confirm the immune-modulatory effect of lenvatinib. After obtaining informed consent from patients, we prospectively collected 20 ml of whole blood a...
Autores principales: | Jin, Meihua, Kim, Chae A., Bae, Dong Jun, Kim, Sang-Yeob, Kim, Tae Yong, Kim, Won Bae, Shong, Young Kee, Kim, Won Gu, Jeon, Min Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406916/ https://www.ncbi.nlm.nih.gov/pubmed/37550394 http://dx.doi.org/10.1038/s41598-023-39503-w |
Ejemplares similares
-
Graves’ disease diagnosed in remnant thyroid after lobectomy for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2022) -
Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
por: Kim, Won Bae, et al.
Publicado: (2020) -
Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2021) -
Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2022) -
Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
por: Jin, Meihua, et al.
Publicado: (2020)